ID
42548
Descripción
Study ID: 110921 Clinical Study ID: 110921 Study Title: A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00811733 Clinicaltrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT00811733 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Ofatumumab Trade Name: N/A Study Indication: Waldenstrom Macroglobulinaemia The primary objective of this open-label, multi-center, Phase II study was to evaluate the safety and efficacy of Ofatumumab in subjects diagnosed with Waldenstrom Macroglobulinaemia. For the study, eligible subjects were enrolled to receive up to 3 cycles of treatment with Ofatumumab. The first cycle consisted of a single dose of 300 mg followed by 3 weekly doses of 1000 mg (Treatment Group A) or 4 weekly doses of 2000 mg (Treatment Group B) of Ofatumumab, with response assessment beginning at Week 12. Based on the Week 12-16 response, eligible subjects could receive up to 2 additional cycles of treatment. This form has to be filled out whenever/if Pharmacogenetic Research consent has to be given/withdrawn or blood samples have to be collected during study.
Link
https://clinicaltrials.gov/ct2/show/NCT00811733
Palabras clave
Versiones (1)
- 25/8/21 25/8/21 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
25 de agosto de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733
Pharmacogenetic Research
- StudyEvent: ODM
Descripción
Pharmacogenetic (PGx) Research Consent/Blood Sample Collection
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0021430
- UMLS CUI-3
- C0005834
Descripción
Informed consent for PGx research
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Descripción
Informed consent for PGx research, Date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C0011008
Descripción
Blood sample for PGx research
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0005834
- UMLS CUI [1,2]
- C2347500
Descripción
Blood sample for PGx research, Date sample taken
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0005834
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C1302413
Descripción
No informed consent for PGx research, reason
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1298908
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C2347500
- UMLS CUI [1,4]
- C0566251
Descripción
No informed consent for PGx research, other reason
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1298908
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C2347500
- UMLS CUI [1,4]
- C0566251
- UMLS CUI [1,5]
- C0205394
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2347029
Descripción
Withdrawal of Consent for PGx (DNA) / Blood Sample Destruction
Alias
- UMLS CUI-1
- C1707492
- UMLS CUI-2
- C2347500
- UMLS CUI-3
- C1948029
- UMLS CUI-4
- C0178913
Descripción
Consent withdrawn for PGx research
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C2347500
Descripción
Consent withdrawn for PGx research, Date
Tipo de datos
partialDate
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C0011008
Descripción
Please replace 'blood' with the appropriate sample type as specified in the protocol.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1272683
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C0178913
- UMLS CUI [1,4]
- C2347500
Descripción
Please replace 'blood' with the appropriate sample type as specified in the protocol. Screen failure is an optional choice.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1272683
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C0178913
- UMLS CUI [1,4]
- C0566251
- UMLS CUI [1,5]
- C2347500
Descripción
Please replace 'blood' with the appropriate sample type as specified in the protocol.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1272683
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C0178913
- UMLS CUI [1,4]
- C0566251
- UMLS CUI [1,5]
- C0205394
- UMLS CUI [1,6]
- C2347500
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2347029
Similar models
Pharmacogenetic Research
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0021430 (UMLS CUI-2)
C0005834 (UMLS CUI-3)
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C1302413 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0021430 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,5])
C2347500 (UMLS CUI-2)
C1948029 (UMLS CUI-3)
C0178913 (UMLS CUI-4)
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C2347500 (UMLS CUI [1,4])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C2347500 (UMLS CUI [1,5])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,5])
C2347500 (UMLS CUI [1,6])
Sin comentarios